✦ LIBER ✦

Cancer-associated tumour markers CA 19-9 and CA-50 in patients with pancreatic cancer with special reference to the Lewis blood cell status

✍ Scribed by Masson, P; Pålsson, B; Andrén-Sandberg, Å

Book ID: 109836420
Publisher: Nature Publishing Group
Year: 1990
Tongue: English
Weight: 686 KB
Volume: 62
Category: Article
ISSN: 0007-0920
DOI: 10.1038/bjc.1990.241

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Estimating prognosis and palliation base

Estimating prognosis and palliation based on tumour marker CA 19-9 and quality of life indicators in patients with advanced pancreatic cancer receiving chemotherapy

✍ Bernhard, J; Dietrich, D; Glimelius, B; Hess, V; Bodoky, G; Scheithauer, W; Herr 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 371 KB

Doubling time of serum CA 19-9 in the cl

Doubling time of serum CA 19-9 in the clinical course of patients with pancreatic cancer and its significant association with prognosis

✍ Nishida, Koichi; Kaneko, Toshiro; Yoneda, Mitsuru; Nakagawa, Shuji; Ishikawa, Ta 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 2 views

Background and Objectives: Pancreatic cancer is generally a disease with a poor prognosis, and relationship between change of serum CA 19-9 level and progression of this disease was investigated with regard to clinical pace of disease and tumor growth. Methods: CA 19-9 doubling time was examined in